Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo

24 Jan 2017

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Mosquito-borne diseases and control
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 28117345
DOI: 10.1038/cr.2017.16

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivoPMID 28117345Read ↗

Tackling hepatitis B Virus with CRISPR/Cas9: advances, challenges, and delivery strategiesSemantic proximity Read ↗

CRISPR/Cas9 for hepatitis B virus infection treatmentSemantic proximity Read ↗

Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited DiseasesSemantic proximity Read ↗

Recent Progress and Future Prospective in HBV Cure by CRISPR/CasSemantic proximity Read ↗

CRISPR/Cas and Hepatitis B Therapy: Technological Advances and Practical BarriersSemantic proximity Read ↗

Development of an in vivo delivery system for CRISPR/Cas9-mediated targeting of hepatitis B virus cccDNASemantic proximity Read ↗

Viral Delivery Systems for CRISPRSemantic proximity Read ↗

Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular CarcinomaSemantic proximity Read ↗

Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applicationsSemantic proximity Read ↗

Application of CRISPR/Cas9 Technology to HBVSemantic proximity Read ↗

The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startupsSemantic proximity Read ↗

Viral delivery of compact CRISPR-Cas12f for <i>in vivo</i> gene editing applicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.